SFG
IBB icon

SNS Financial Group’s iShares Biotechnology ETF IBB Stock Holding History

SNS Financial Group’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-3,000
Closed -$260K – 128
2015
Q3 		$260K Buy
+3,000
New +$360K 0.07% 98

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.9% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

SNS Financial Group's IBB Position: Q2 2026 in Review

SNS Financial Group opened a new position in iShares Biotechnology ETF (IBB) in Q2 2026: 1,795 shares worth $341K. The stake represents 0.01% of the portfolio and ranks #438 among its holdings. This is a return to the name: SNS Financial Group previously reported a position in IBB as recently as Q3 2017.

SNS Financial Group first reported a position in IBB in Q2 2014 and has held it in 4 quarters since. The position peaked at $2M in Q2 2014. 960 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • SNS Financial Group held 1,795 shares of iShares Biotechnology ETF worth $341K as of Q2 2026.
  • iShares Biotechnology ETF was a new SNS Financial Group position in Q2 2026.
  • iShares Biotechnology ETF made up 0.01% of SNS Financial Group's portfolio in Q2 2026, its #438 holding.
  • SNS Financial Group first reported a position in iShares Biotechnology ETF in Q2 2014 and has held it in 4 quarters since.
  • SNS Financial Group's iShares Biotechnology ETF position peaked at $2M in Q2 2014.
  • 960 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on SNS Financial Group's 13F filing for Q2 2026, filed 11 Aug 2026.